Table 2.
Clinical symptoms of ATBL in the hematogenous dissemination group and the non- hematogenous dissemination group
| Clinical Symptoms | Hematogenous Dissemination group (n = 75) | Non-hematogenous Dissemination group (n = 103) | P |
|---|---|---|---|
| Asymptomatic | 1 (1.3%) | 6 (5.8%) | 0.241 |
| Abdominal pain | 41 (54.7%) | 66 (64.1%) | 0.205 |
| Abdominal distension | 20 (26.7%) | 45 (43.7%) | 0.020 |
| Diarrhea | 5 (6.7%) | 14 (13.6%) | 0.140 |
| Hematochezia | 1 (1.3%) | 6 (5.8%) | 0.241 |
| Constipation | 0 (0.0%) | 2 (1.9%) | 0.510 |
| Increased frequency of defecation | 0 (0.0%) | 1 (1.0%) | 1.000 |
| Rectal tenesmus | 0 (0.0%) | 2 (1.9%) | 0.510 |
| The changes of character of stool | 1 (1.3%) | 4 (3.9%) | 0.399 |
| Intestinal obstruction | 0 (0.0%) | 1 (1.0%) | 1.000 |
| Fever | 26 (34.7%) | 28 (27.2%) | 0.284 |
| Loss of appetite | 18 (24.0%) | 16 (15.5%) | 0.156 |
| Night sweat | 10 (13.3%) | 17 (16.5%) | 0.560 |
| Weak | 12 (16.0%) | 8 (7.8%) | 0.086 |
| Loss of weight | 8 (10.7%) | 5 (4.9%) | 0.141 |
| Cough and sputum production | 21 (28.0%) | 16 (15.5%) | 0.043 |
| Breathless | 6 (8.0%) | 2 (1.9%) | 0.071 |
| Chest pain | 2 (2.7%) | 2 (1.9%) | 1.000 |
| Tightness in the chest | 0 (0.0%) | 1 (1.0%) | 1.000 |
| Nausea and vomiting | 3 (4.0%) | 7 (6.8%) | 0.522 |
| Headache | 2 (2.7%) | 0 (0.0%) | 0.176 |
| Dizzy | 1 (1.3%) | 0 (0.0%) | 0.421 |
| Superficial lymph node enlargement | 5 (6.7%) | 0 (0.0%) | 0.012 |
| Abdominal mass | 1 (1.3%) | 1 (1.0%) | 1.000 |
ATBL, abdominal tuberculous lymphadenopathy